Table 3.
Univariate analysis for Overall Survival (OS) in all patients
| Variable | Pts n° | 5-year 0S | 95% CI | p | |
|---|---|---|---|---|---|
| Age | < 26 yrs | 4 | 25 | 0–67 | 0.6 |
| 26 – 65 yrs | 42 | 23 | 10–36 | ||
| > 65 yrs | 14 | 11 | 0–32 | ||
| Gender | M | 38 | 25 | 11–39 | 0.4 |
| F | 22 | 13 | 0–28 | ||
| Stage | localized | 36 | 33 | 17–50 | 0.0001 |
| metastatic | 24 | 0 | |||
| Size* | < 10 cm | 22 | 33 | 13–54 | 0.09 |
| ≥ 10 cm | 29 | 11 | 0–23 | ||
| Site | extremity | 38 | 29 | 14–44 | 0.1 |
| central | 22 | 6 | 0–17 | ||
| Chemotherapy** | yes | 28 | 22 | 6–38 | 0.11 |
| no | 29 | 22 | 7–39 | ||
| SCR | yes | 30 | 46 | 29–63 | 0.0001 |
| no | 30 | 0 |
M: male; F: Female; SCR: surgical complete remission
Size was known in 51 patients;
Chemotherapy information was available for 57 patients